Insulet Corporation (PODD)
NASDAQ · Healthcare · Medical Devices
Insulet Corporation is a Healthcare company with a market capitalization of $10.04B and a trailing P/E ratio of 27.1.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 6, 2026 | $1.42 | $1.19 | +19.3% |
| Q4 2025 | February 18, 2026 | $1.55 | $1.48 | +4.7% |
| Q3 2025 | November 6, 2025 | $1.24 | $1.15 | +7.8% |
| Q2 2025 | August 7, 2025 | $1.17 | $0.93 | +25.8% |
| Q1 2025 | May 8, 2025 | $1.02 | $0.79 | +29.1% |
| Q4 2024 | February 20, 2025 | $1.15 | $1.02 | +12.6% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 4,645,027 | 6.62% | 3.6 | -4.3% |
| June 30, 2026 | 4,853,706 | 6.91% | 2.8 | -1.0% |
| June 15, 2026 | 4,902,738 | 6.98% | 3.5 | +15.8% |
| May 29, 2026 | 4,232,806 | 6.03% | 2.6 | +40.4% |
| May 15, 2026 | 3,014,097 | 4.29% | 1.6 | +1.5% |
| April 30, 2026 | 2,968,238 | 4.20% | 2.4 | +9.9% |
| April 15, 2026 | 2,700,832 | 3.82% | 3.2 | -11.4% |
| March 31, 2026 | 3,049,595 | 4.32% | 3.5 | +19.3% |
Other Medical Devices Stocks
Frequently Asked Questions
What is Insulet Corporation's market cap?
As of August 13, 2026, Insulet Corporation (PODD) has a market capitalization of $10.04B.
What is Insulet Corporation's P/E ratio?
Insulet Corporation trades at a trailing price-to-earnings (P/E) ratio of 27.1. Its forward P/E is 23.9.
Does Insulet Corporation pay a dividend?
Insulet Corporation does not currently pay a dividend.
What sector is PODD in?
Insulet Corporation is in the Healthcare sector, specifically the Medical Devices industry.
What is Insulet Corporation's short interest?
As of the July 15, 2026 FINRA settlement, 4,645,027 PODD shares were sold short, or 6.62% of shares outstanding. Days to cover: 3.6. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was Insulet Corporation's revenue?
In its latest reported fiscal year (ending December 31, 2025), Insulet Corporation reported revenue of $2.71B and net income of $247.10M.
Ask your own questions about PODD
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.